Company profile: Protedyne
1.1 - Company Overview
Company description
- Provider of laboratory automation systems that integrate powerful laboratory robotic hardware and industrial automation design principles, bringing serious laboratory automation to LabCorp's diagnostic testing facilities nationwide and supporting existing pharmaceutical, biotech, and diagnostic testing customers as a wholly owned subsidiary of Laboratory Corporation of America.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Protedyne
Xcellerex
HQ: United States
Website
- Description: Provider of biomanufacturing technologies, developing and producing biomanufacturing systems and production-scale bioreactors that transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines. Offers OptiRun service solutions including maintenance, upgrades, calibration, remote support, plus equipment installation and qualification, scientific support, and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcellerex company profile →
PathogenDx
HQ: United States
Website
- Description: Provider of RT-PCR and DNA microarray-based pathogen detection solutions, including assays for SARS-CoV-2 genes and variants (DetectX-Rv, DetectX-Cv), environmental SARS-CoV-2 screening (EnviroX-Rv), a UTI panel detecting 26 pathogens and 12 antibiotic resistance markers (D3 Array-UTI), and semi-quantitative fungal and bacterial assays (QuantX Fungal, QuantX Bacterial).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PathogenDx company profile →
Akonni Biosystems
HQ: United States
Website
- Description: Provider of genetic testing and molecular diagnostic solutions, including TruDiagnosis microarray-based multiplex analysis of infectious diseases; TruTip DNA/RNA extraction and the Automated Workstation; TruDx2000 near point-of-care amplification/detection platform; TruDx3000 sample-in, answer-out testing system; and Lab-on-a-Film microfluidic disposables for low-cost diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akonni Biosystems company profile →
PharmaDiagnostics
HQ: Belgium
Website
- Description: Provider of analytical techniques and assay systems to accelerate the drug discovery process, offering human albumin binding, human orosomucoid, membrane, and redox potential assays, plus experimental pKa, experimental log D, P-glycoprotein interaction, and Cytochromes P450 assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaDiagnostics company profile →
Groupe Carso
HQ: France
Website
- Description: Provider of environmental and agrifood analytical services, including testing of water and environmental elements (soils, waste, biomass, emissions, air quality), food and animal nutrition sampling and analyses, industrial hygiene and building health services (chemical risk, pollutant concentrations, radioprotection), forensic analyses (genetic/digital fingerprinting, blood trace, electronic/computer evidence), high-throughput DNA sequencing, and lab outsourcing support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Groupe Carso company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Protedyne
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Protedyne
2.2 - Growth funds investing in similar companies to Protedyne
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Protedyne
4.2 - Public trading comparable groups for Protedyne
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →